SEC Form 4 · accession 0000899243-18-019862
OMEROS CORP · OMER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marcia S. Kelbon
Officer — VP Patent and General Counsel
Period of report
Jul 12, 2018
Accepted (ET)
Jul 13, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 12, 2018 | M | 4,277 | $4.10 | A | 188,922 | D | |
| Common StockF2 | Jul 12, 2018 | S | 4,277 | $21.4838 | D | 184,645 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $4.10 | Jul 12, 2018 | M | 4,277 | D | — | Jan 7, 2022 | Common Stock | 4,277 | 83,252 | D |
Explanation of responses
- F1Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, and amended on May 17, 2018. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2This transaction was executed in multiple trades at prices ranging from $21.46 to $21.49; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- F3The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011.